This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine

Sponsored by GlaxoSmithKline

About this trial

Last updated 9 years ago

Study ID

776423/001

Status

Completed

Type

Interventional

Phase

Phase 3

Placebo

No

Accepting

18-75 Years
10 to 18 Years
All
All

Trial Timing

Ended 21 years ago

What is this trial about?

This study will evaluate the safety and immune response to GlaxoSmithKline Tdap vaccine compared to licensed Td vaccine when used as a booster in healthy adolescents (10-18 years of age).

What are the participation requirements?

Yes

Inclusion Criteria

- Healthy adolescents with history of completed routine vaccination against diphtheria, tetanus, and pertussis (DTP).

No

Exclusion Criteria

- Use of any other investigational drug or vaccine 30 days preceding study vaccination.

- Chronic administration of immunosuppressants.

- Administration of pre-school DTP vaccine within previous 5 years.

- Administration of Td booster within previous 10 years.

Locations

Location

Status